2021
Neonatal Abstinence Syndrome: Management Advances and Therapeutic Approaches
Cheng F, McMillan C, Morrison A, Berkwitt A, Grossman M. Neonatal Abstinence Syndrome: Management Advances and Therapeutic Approaches. Current Addiction Reports 2021, 8: 595-604. DOI: 10.1007/s40429-021-00387-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNeonatal abstinence syndromeMaternal-infant dyadsNon-pharmacologic interventionsNumber of infantsDevelopment of NASOpioid crisisLong-term neurodevelopmental outcomesNon-pharmacologic careOpioid-exposed infantsProportion of infantsLength of stayPurpose of ReviewInBirth hospitalizationOutpatient managementInpatient managementNeurodevelopmental outcomesClinical presentationAbstinence syndromeVulnerable infantsPharmacologic agentsStrategy warrantsClinical pathwayTherapeutic approachesFunctional assessmentInfants
2015
The Utility of Inpatient Rebound Bilirubin Levels in Infants Readmitted After Birth Hospitalization for Hyperbilirubinemia
Berkwitt A, Osborn R, Grossman M. The Utility of Inpatient Rebound Bilirubin Levels in Infants Readmitted After Birth Hospitalization for Hyperbilirubinemia. Hospital Pediatrics 2015, 5: 74-78. PMID: 25646199, DOI: 10.1542/hpeds.2014-0074.Peer-Reviewed Original ResearchConceptsBilirubin levelsLength of stayBirth hospitalizationIndirect hyperbilirubinemiaRebound groupDiscontinuation of phototherapyRetrospective cohort studyManagement of infantsCharacteristics of childrenCohort studySecondary outcomesHospital readmissionPrimary outcomePatient populationSubgroup analysisClinical utilityPatientsInfantsHospitalizationHyperbilirubinemiaPhototherapyReadmissionStayDlPresent study